Cargando…
Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy
Phage display is a nanotechnology with limitless potential, first developed in 1985 and still awaiting to reach its peak. Awarded in 2018 with the Nobel Prize for Chemistry, the method allows the isolation of high-affinity ligands for diverse substrates, ranging from recombinant proteins to cells, o...
Autores principales: | Goracci, Martina, Pignochino, Ymera, Marchiò, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071019/ https://www.ncbi.nlm.nih.gov/pubmed/32075083 http://dx.doi.org/10.3390/molecules25040843 |
Ejemplares similares
-
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application
por: Agnoletto, Chiara, et al.
Publicado: (2023) -
Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy
por: França, Renato Kaylan Alves, et al.
Publicado: (2023) -
Phage display as a tool for vaccine and immunotherapy development
por: Hess, Krystina L., et al.
Publicado: (2019) -
Nanotechnology-based products for cancer immunotherapy
por: Shams, Forough, et al.
Publicado: (2021) -
Current applications and future prospects of nanotechnology in cancer immunotherapy
por: Yan, Sen, et al.
Publicado: (2019)